Political Declaration on HIV and AIDS: On the Fast Track to Accelerating the Fight against HIV and to Ending the AIDS Epidemic by 2030 A/RES/70/266 procurement and equitable distribution are also developed, and , in this context, encourage other forms of incentives for research and development such as the exploration of new incentive systems, including those in which research and development costs are delinked from product prices; 64 (e). Recognize the important role played by the private sector in research and development of innovative medicines, encourage the use, where appropriate, of alternative financing mechanisms for research and development as a driver of innovation for new medicines and new uses for medicines and explore opportunities to delink the cost of research and development fro m the price of health products; 64 (f). Commit to realizing the full impact of innovation in research, science and technology and to working towards ensuring that trade and other commercial policies support public health goals under a human rights and development framework; 64 (g). Recognize that the changing context, epidemic and response demand expanded quality technical support to strengthen capacity and institutions aligned with principles of country ownership and leadership, aid effectiveness and value for money and that long-term sustainability of access to HIV-related products, including through local production of pharmaceutical products, requires promoting voluntary technology transfer on mutually agreed terms, including sharing of know how and expertise to strengthen local manufacturing capacity; 64 (h). Commit to supporting technology transfer arrangements which increase the availability and affordability of medicines and related health technologies and , in this regard, encourage the utilization of the multi-stakeholder forum on science, technology and innovation for the Sustainable Development Goals, created as a component of the Technology Facilitation Mechanism, to identify and examine technology needs and gaps; 64 (i). Support and encourage, through domestic and international funding and the provision of technical assistance, the substantial development of human capital, development of national and international research infrastructures, laboratory capacity and improved surveillance systems, and data collection, processing and dissemination, and training of basic and clinical researchers, social scientists and technicians, with a focus on those countries most affected by HIV and/or experiencing or at risk of a rapid expansion of the epidemic; Leveraging regional leadership and institutions is essential to more effective AIDS responses 65. Encourage all regions to work with regional and subregional organizations, people living with, at risk of and affected by HIV, relevant United Nations system organizations, the private sector and other relevant stakeholder s towards the achievement of the following targets by 2020, as modelled in the fast-track approach to ending the AIDS epidemic by 2030, and, in this regard, call for strengthened global solidarity and shared responsibility to ensure that sufficient funds are made available to support regions in this endeavour: 65 (a). Work towards reducing the number of new infections among young people and adults (aged 15 and older) by 75 per cent in Asia and the Pacific to 88,000, in Eastern Europe and Central Asia to 44,000, in Eastern and Southern Africa to 210,000, in Latin America and the Caribbean to 40,000, in the Middle East and North Africa to 6,200, in Western and Central Africa to 67,000 and in Western and Central Europe and North America to 53,000; 23/26